Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis.
Diabetes, obesity & metabolism（2023）
摘要
Tirzepatide provides better value for money than semaglutide for weight reduction.
更多查看译文
关键词
cost-effectiveness,obesity therapy,type 2 diabetes,weight control
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要